Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site

作者: Sylvain Rault , Pierrick Auvray , Safa Moslemi , Pascal Sourdaine , Sébastien Galopin

DOI: 10.1016/S0223-5234(98)80046-9

关键词:

摘要: Abstract We developed a new comparative model in order to better understand the structure-function relationships of active site human aromatase. Thus, we undertook inhibition and equine aromatases with compounds. In fact, aromatase represents only easy available mammalian membrane-bound enzyme model, besides one, which is biochemically purified, well characterized cloned. During course our work concerning synthesis screening drugs on aromatases, identified two indane derivatives inhibited (IC 50 = 3.5 μM 5.9 μM) strongly selectively while they were much less one > 10 μM). The hitherto known inhibitors, such as 4-hydroxyandrostenedione (4-OHA) some other indane-related derivatives, are equally efficient both enzymes. this work, using theoretical 3D aromatase, have explained selectivity described compounds due specific differences between primary structure sites These results could allow family that more potent selective inhibitors.

参考文章(35)
Charles A. Laughton, Yeh-Chih Kao, Dujin Zhou, Shiuan Chen, Linh L. Cam, Binding Characteristics of Seven Inhibitors of Human Aromatase: A Site-directed Mutagenesis Study Cancer Research. ,vol. 56, pp. 3451- 3460 ,(1996)
J.L. Gaillard, P. Silberzahn, Aromatization of 19-norandrogens by equine testicular microsomes Journal of Biological Chemistry. ,vol. 262, pp. 5717- 5722 ,(1987) , 10.1016/S0021-9258(18)45634-7
E. Aubrey Thompson, Pentti K. Siiteri, The Involvement of Human Placental Microsomal Cytochrome P-450 in Aromatization Journal of Biological Chemistry. ,vol. 249, pp. 5373- 5378 ,(1974) , 10.1016/S0021-9258(20)79736-X
L. Banting, Inhibition of aromatase. Progress in Medicinal Chemistry. ,vol. 33, pp. 147- 184 ,(1996) , 10.1016/S0079-6468(08)70305-9
T. Sergejew, R. W. Hartmann, Pyridyl substituted benzocycloalkenes: new inhibitors of 17 alpha-hydroxylase/17,20-lyase (P450 17 alpha). Journal of Enzyme Inhibition. ,vol. 8, pp. 113- 122 ,(1994) , 10.3109/14756369409020194
C. Batzl, A. Bhatnagar, E. Francotte, G. Rihs, M. Lang, P. Furet, Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds. Journal of Medicinal Chemistry. ,vol. 36, pp. 1393- 1400 ,(1993) , 10.1021/JM00062A012
Angela M.H. Brodie, Wesley M. Garrett, James R. Hendrickson, Chon-Hwa Tsai-Morris, Patrick A. Marcotte, Cecil H. Robinson, Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo Steroids. ,vol. 38, pp. 693- 702 ,(1981) , 10.1016/0039-128X(81)90087-8
Walter Wouters, Eric Snoeck, Roland De Coster, Vorozole, a specific non-steroidal aromatase inhibitor. Breast Cancer Research and Treatment. ,vol. 30, pp. 89- 94 ,(1994) , 10.1007/BF00682743
C.A. Laughton, M.J.J.M. Zvelbil, S. Neidle, A detailed molecular model for human aromatase The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 44, pp. 399- 407 ,(1993) , 10.1016/0960-0760(93)90243-P